Recent news on Montelukast

Focus shifts to Merck's Gardasil as new adverse events uncovered  -  25 May 2007
Pharma Times (subscription),...first quarter growth of 12% driven by its asthma agent Singulair (montelukast), as well as newer agents Januvia (sitagliptin) for diabetes and Gardasil.

ATS: Asthma Control in Kids May Not Follow Consistent Inhaler Use  -  25 May 2007
MedPage Today,Furthermore, the study was done before some of the newer asthma medications, such as montelukast (Singulair) and other leukotriene receptor antagonists were

Good news for for people with mild, persistent asthma  -  May 20, 2007
News-Medical.net,He said that even though montelukast had a higher rate of treatment failure than the inhaled medications, it can also be considered an option for some

New Indication For SINGULAIR® (Montelukast Sodium) Approved To ...  -  Apr 27, 2007
Medical News Today (press release),Patients already taking one tablet daily SINGULAIR® (montelukast sodium) is a registered trademark of Merck & Co., Inc. for another indication,

New Indication for SINGULAIR® (montelukast sodium) Approved to ...  -  Apr 30, 2007
WebWire (press release),...(montelukast sodium) to prevent exercise-induced bronchoconstriction (EIB; also known as exercise-induced asthma) in patients aged 15 years and older.

Once a day treatment may be option for mild asthma cases  -  May 16, 2007
CBC Toronto,Although the treatment failure rate among people who switched to montelukast was higher at about 30 per cent, it should also be considered an option for

New Ways to Quell Mild Persistent Asthma  -  May 16, 2007
MedPage Today,The failure rate for montelukast was about 60% higher than either of the other treatments (the hazard ratio for both comparisons was 1.6 with a 95%

Mild Asthmatics May Do Well With Less Medicine  -  May 16, 2007
drkoop.com...medications that include inhaled corticosteroids and rescue medications known as beta agonists, or to the oral medication, montelukast (Singulair).

Once Daily Treatment for Well Controlled Asthma  -  May 16, 2007
Insider Medicine,The researchers found that 70% of the patients receiving montelukast continued to have good asthma control while 80% of patient receiving twice-daily

Treatment of Mild Persistent Asthma  -  May 16, 2007
New England Journal of Medicine (subscription),Although not approved by the FDA for once-daily dosing, this treatment appears to provide better asthma control than once-daily oral montelukast and greater

Singulair Approved for Exercise-Induced Asthma  -  Apr 25, 2007
Atlanta Journal Constitution (subscription),WEDNESDAY, April 25 (HealthDay News) -- The US Food and Drug Administration has approved the Merck asthma and allergy drug Singulair (montelukast sodium)

Singulair Approved for Exercise-Induced Asthma  -  Apr 25, 2007
Forbes,...and allergy drug Singulair (montelukast sodium) for people aged 15 and older who experience asthma symptoms during exercise, the company said Wednesday.

Merck & Co gets additional FDA approval for Singulair  -  Apr 26, 2007
Pharma Times (subscription),The US Food and Drug Administration has cleared Singulair (montelukast) to prevent exercise-induced bronchoconstriction (EIB), also known as

Asthma treatments are promising  -  May 21, 2007
Ventura County Star (subscription),A third alternative, the pill montelukast (Singulair), also prevented asthma attacks but not as well as the other choices, the study found.

Analysis: Asthma patients can cut dose  -  May 17, 2007
United Press International...one daily dose of Advair Diskus (fluticasone plus salmeterol), and the remaining 166 patients to receive a once-daily dose of Singulair (montelukast).

Simpler asthma treatment options found effective  -  May 17, 2007
News from Washington University in St. Louis,They used once-daily montelukast (Singulair®), a non-steroid anti-inflammatory drug taken in pill form. Thirty percent of these participants experienced

Asthma sufferers get room to breathe  -  May 17, 2007
Independent Online,A third group took a once-daily pill known as montelukast sodium, or Singulair, sold by Merck & Co. Singulair works by blocking the protein leukotriene and

Once-daily treatment OK for mild asthma - study  -  May 16, 2007
Reuters India,A third group took a once-daily pill known as montelukast sodium, or Singulair, sold by Merck & Co. Inc. Singulair works by blocking the protein leukotriene

New Options for Mild Asthma  -  May 16, 2007
Ivanhoe,...of fluticasone propionate and salmeterol in a single inhaler (Advair® Discus) once a day; or the oral medication montelukast (Singulair®) once a day.

Recommendations for Treating Asthma in Pregnancy  -  May 8, 2007
Medscape (subscription)The leukotriene modifiers montelukast and zafirlukast are labeled as pregnancy category B and may be continued among women who received these agents prior

Early onset of cystic fibrosis studied  -  May 2, 2007
Science Daily (press release)Children's asthma drug elicits good review (February 15, 2007) -- An Australian study shows children taking the prescription drug montelukast for

Merck's Singulair approved to prevent exercise-induced ...  -  Apr 27, 2007
SpiritIndia,Merck & Co., Inc. announced that the US Food and Drug Administration (FDA) has approved a new indication for SINGULAIR® (montelukast sodium) to prevent

New Indication for SINGULAIR® (montelukast sodium) Approved to ...  -  26 Apr 2007
Emediawire (press release),Merck & Co., Inc. announced today that the US Food and Drug Administration (FDA) has approved a new indication for SINGULAIR® (montelukast sodium) to

Merck's Q1 profit rises  -  Apr 20, 2007
Pharma Times (subscription),The blockbuster and highlight of the Merck stable, Singulair (montelukast) for the treatment of chronic asthma and allergic rhinitis, added to earning by

Chronic hives: What causes them?  -  Apr 10, 2007
MayoClinic.comLeukotriene inhibitors, such as montelukast, also have been tried as a treatment for chronic hives but require further study.

Waiting to exhale  -  Apr 1, 2007
Business Standard,A fairly new agent that has come out is the leukotriene receptor antagonist, known as montelukast, that considerably reduces the overwhelming immune

Drug Makes Asthma Easier to Manage  -  25 Feb 2007
drkoop.comResearchers from the Royal Children's Hospital in Melbourne, Australia, studied 202 children with intermittent asthma to determine if the drug Montelukast

Drug montelukast reduces trips to doctor for childhood asthma attacks  -  Feb 15, 2007
News-Medical.net,Young children with attacks of sporadic, recurring asthma who were treated with the prescription drug montelukast by their parents had fewer unscheduled

Drug Reduces Unscheduled Trips to Doctor for Childhood Asthma Attacks  -  Feb 15, 2007
DG NewsNEW YORK, NY -- February 15, 2007 -- Young children with attacks of sporadic, recurring asthma who were treated with the prescription drug montelukast by

Asthma drug keeps kids from missing school  -  Feb 16, 2007
Asbury Park Press,In young children with sporadic, recurring asthma attacks, treatment with the drug montelukast (Singulair) reduces the number of unscheduled medical visits,

Asthma Drug Keeps Kids From Missing School  -  Feb 15, 2007
Austin American-Statesman (subscription),The group of children who received montelukast had a total of 163 unscheduled medical visits during that year, compared to 228 for the group that received

Children's Asthma Drug Elicits Good Review  -  Feb 15, 2007
Post ChronicleAn Australian study shows children taking the prescription drug montelukast for reoccurring sporadic asthma miss fewer school days.

Asthma drug provides effective treatment for immune reconstitution ...  -  Jan 31, 2007
Aidsmap,During therapy with montelukast the individual remained on antiretroviral therapy without experiencing any additional adverse effects, his viral load

Kids With Asthma Lose Fewer School Days on Leukotriene Antagonist  -  Feb 15, 2007
MedPage Today,15 -- For children with intermittent asthma, a short course of Singulair (montelukast) given at the first sign of an episode may reduce acute care visits,

Inhalers Beat Pill for Asthma  -  Jan 28, 2007
drkoop.com...(Serevent) combination (salmeterol is another type of inhaled drug called a long-acting beta2 agonist) and the tablet Montelukast (Singulair).

lower steroid dose for asthmatic kids  -  Feb 13, 2007
NorthJersey.com,...or salmeterol) in the morning and Serevent again at night; or to take a chewable tablet of Singulair (montelukast), a leukotriene modifier, at night.

Charges and falling Zocor sales hit Merck & Co's earnings  -  Jan 31, 2007
Pharma Times (subscription),Other financial highlights included a 17% increase in sales of asthma drug Singulair (montelukast) to $960 million, while vaccine revenues more than doubled

Health Guide: Asthma and Medications  -  Jan 2, 2007
Market-Day.net,Cromolyn Sodium or NedocromilSodium Inhalers, pills such as Zafirlukast, Zileuton, and Montelukast,Corticosteroids, Theophylline, and Epinephrine shots.

Merck & Co keeps profit forecasts conservative for 2007  -  Dec 7, 2006
Pharma Times (subscription),The company also released 2007 sales predictions for some better-established products: $3.7-$4 billion for asthma drug Singulair (montelukast);

Asthma: 3 steps to better asthma control  -  Dec 12, 2006
MayoClinic.comExamples include montelukast (Singulair) and zafirlukast (Accolate). Cromolyn (Intal) and nedocromil (Tilade). These medications, taken by inhalation,

Research and Markets: Cipla Manufactures Apis And Formulation ...  -  Nov 27, 2006
PharmaLive.com (press release),Other firsts have included propranolol, ondansetron, salmeterol, montelukast, fluticasone propionate and doxazosin. In 2006, the company announced it was

Preventing aggravation of allergy-like symptoms during Ramazan  Oct 13, 2006
A study undertaken last year has indicated the efficacy of a new anti-asthma drug, Montelukast, as an effective preventative measure for viral respiratory ... -The News - International, Research and Markets: Examine Financial Performance of Merck & Co ...  Oct 9, 2006
Singulair (montelukast) is a once-daily, long-acting oral leukotriene D4-receptor antagonist indicated for the treatment of asthma. ... -Genetic Engineering News (press release), Asthma treatment approved by Health Canada for relief of symptoms ...  Sep 19, 2006
...announced today that SINGULAIR(R) (montelukast sodium), has also been approved for the relief of symptoms of seasonal allergic rhinitis (AR), also known as hay ... -Canada NewsWire

Asthma Treatment Approved By Health Canada for Relief of Symptoms ...  Sep 19, 2006
...announced today that Singulair(R) (montelukast sodium), has also been approved for the relief of symptoms of seasonal allergic rhinitis (AR), also known as hay ... -DG News

Antibiotics may be option for asthma  Sep 20, 2006
The University of Wisconsin is also involved in another study, Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma, or MARS ... -South Bend Tribune

Asthma: 3 steps to better asthma control  -  12 Dec 2006
MayoClinic.comExamples include montelukast (Singulair) and zafirlukast (Accolate). Cromolyn (Intal) and nedocromil (Tilade). These medications, taken by inhalation,

Merck & Co keeps profit forecasts conservative for 2007  -  Dec 7, 2006
Pharma Times (subscription),The company also released 2007 sales predictions for some better-established products: $3.7-$4 billion for asthma drug Singulair (montelukast);

Critical Therapeutics Announces Efficacy Data for Controlled ...  -  Nov 15, 2006
PharmaLive.com (press release),Increased airway eosinophils were reduced at 8 hours in the zileuton and montelukast treatment groups. However, neutrophils were largely inhibited by

Research and Markets: Cipla Manufactures Apis And Formulation ...  -  Nov 27, 2006
PharmaLive.com (press release),Other firsts have included propranolol, ondansetron, salmeterol, montelukast, fluticasone propionate and doxazosin. In 2006, the company announced it was

Antibiotics may be option for treating chronic asthma  Aug 27, 2006
UW is also involved in another study, Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma, or MARS. ... -Milwaukee Journal Sentinel (subscription)

Obesity May Influence Response to Asthma Medications  Aug 22, 2006
Golden says. Singulair is the brand name of montelukast sodium and is sold by Merck & Co., which funded this study. Researchers ... -Newstarget.com

UW Studies Challenge National Asthma Guidelines  Aug 7, 2006
The “MARS� trial (Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma) will assess if children on significant dosages ... -University of Wisconsin-Madison University Communications

Asthma in Children and Adolescents  Jul 26, 2006
The leukotriene-antagonists include zafirlukast (Accolate), montelukast (Singulair), zileuton (Ziflo), and pranlukast (Ultair, Onon). ... -About - News & Issues

Critical Therapeutics: more user-friendly zileuton on the way  Aug 3, 2006
...option. Zileuton belongs to the antileukotriene drug class, which has been dominated by Merck & Co's Singulair (montelukast sodium). ... -PharmaLeader

Room to grow  Jul 7, 2006
...and adults. Becker recently led an international study that pitted a relatively new drug, montelukast, against ICS. The findings ... -Edmonton Sun

PEOPLES PHARMACY Potassium deficiency creates serious risk  Jun 26, 2006
...overused. Other asthma medications that ease inflammation include montelukast (Singulair), zafirlukast (Accolate) or zileuton (Zyflo). ... -Houston Chronicle

Omalizumab for Asthma  Jun 21, 2006
This compares with approximate costs per year of $1,280 for montelukast (Singulair, Merck), $2,160 for the combination of fluticasone dipropionate and ... -New England Journal of Medicine (subscription)

Category: Fairway Woods  Jun 28, 2006
Pantoprazole Tamsulosin [url]http://fastpages.com/bestvalium/tamsulosin.html[/url] [url]http://fastpages.com/bestvalium/montelukast.html[/url] [urlequalshttp ... -Golf-Gear-Review.com



Merck Q1 profits rise despite flat revenues  Apr 21, 2006
Sales of the oral asthma drug Singulair (montelukast) rose 9% to $801 million, and Merck forecast turnover of the product will rise at least 11% this year to ... - Pharma Times (subscription)





American Journal of Respiratory and Critical Care Medicine Vol 173 ...  Mar 28, 2006
...features that determine the differential response of children with mild to moderate asthma to ICS or to the leukotriene receptor antagonist montelukast (25). ... - AJRCCM (subscription)

Over-the-counter Decongestant Equals Popular Prescription Drug in ...  Mar 16, 2006
...found that daily doses of 240 mg of pseudoephedrine hydrochloride (Sudafed® 24 Hour) were just as effective as 10 mg daily of montelukast sodium (Singulair ... - eMaxHealth.com

The Medical Minute: Allergy season in full bloom  Apr 5, 2006
Used as directed, they are safe for the long term. Montelukast, a drug previously used only in asthma, has helped some people with allergic symptoms. ... - Penn State Live

Dr. Time Flannery  Apr 4, 2006
But in a test on 60 patients, those receiving an OTC medication such as Sudafed did just as well as those who took montelukast sodium (Singulair, eg). ... - Belleville News-Democrat

OTC allergy drug may be as effective as prescription  Mar 28, 2006
...assigned 58 adults with ragweed allergies to take Sudafed (pseudoephedrine hydrochloride) or the prescription drug Singulair (montelukast sodium) every morning ... - Pioneer Press

Higher body weight may curb response to steroid puff  Mar 10, 2006
...double-blind trials in which more than 3000 patients with moderate asthma were randomized to the leukotriene antagonist Singulair (montelukast), the inhaled ... - Reuters.uk

Health: Something To Sneeze At  Mar 22, 2006
...at the University of Chicago shows that Sudafed 24 (pseudoephedrine) is as effective as a pricier prescription drug, Singulair (montelukast sodium), in ... - Standard-Speaker

Weighing in on asthma  Mar 21, 2006
On the other hand, the benefit of the Singulair (montelukast) tablet did not show a decrease in effectiveness among the obese and overweight subjects. ... - myDNA.com

Save your money?  Mar 8, 2006
Thirty patients received montelukast (Singulair), and 28 took pseudoephedrine (over-the-counter products). Both treatments did what they were supposed to. ... - Kansas.com

Study targets better asthma treatments  Jan 17, 2006
Researchers administered an inhaled corticosteroid (fluticasone propionate) twice daily or an leukotriene receptor antagonist (montelukast) nightly to more ... - Webindia123

Inhaled Corticosteroids Most Effective for Persistent Asthma in ...  Jan 10, 2006
Response Profiles to Fluticasone and Montelukast in Mild-to-Moderate Persistent Childhood Asthma is featured in the January 2006 issue of the Journal of ... - DG News

ICS Most Effective For Persistent Asthma In Children  Jan 11, 2006
Response Profiles to Fluticasone and Montelukast in Mild-to-Moderate Persistent Childhood Asthma is featured in the January 2006 issue of the Journal of ... - Science Daily

Inhaled Steroid Controls Asthma Better Than Oral Agent  Jan 12, 2006
Their study compared the inhaled corticosteroid Flovent (fluticasone) with the oral leukotriene receptor antagonist Singulair (montelukast) for asthma control ... - CNN

Study Compares Kids' Asthma Drugs  Jan 19, 2006
The children were divided into two groups. One group received an inhaled corticosteroid (fluticasone propionate) twice daily or an LTRA (montelukast) nightly. ... - Forbes

Merck profits edge ahead in fourth quarter  Feb 1, 2006
...in at $1.1 billion, a little ahead of forecasts, on sales of $5.77 billion, helped by a 12% hike in revenues from asthma drug Singulair (montelukast) to $819 ... - Pharma Times (subscription)

Dr. Reddy's Reports Q3 FY06 Revenue of Rs. 5,902 Million; YoY ...  Jan 24, 2006
Sales from Europe increase by 78% to Rs 384 million. This growth was primarily driven by sales of montelukast, terbinafine and omeprazole pellets. ... - Genetic Engineering News

Expression of urocortin in rat lung and its effect on pulmonary ...  Jan 11, 2006
...the mast cell stabilizer cromolyn and histamine-1 (H 1 ) receptor antagonist azelastine respectively, but not by the leukotriene receptor antagonist montelukast ... - Journal of Endocrinology

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional